Just in Time Teaching Tools App Is Launhed by Northwell Health: Available in the Apple Store

December 22, 2020

Just in Time Teaching Tools app to aid in the advancement of medical education knowledge and teaching skills of students, trainees and faculty was announced today by Northwell Health’s Office of Academic Affairs. The app is now available in the Apple Store.

Just in Time Teaching Tools App new app uses the Just-in-time teaching (JiTT) model, a pedagogical approach that involves close interaction between instructors and their classrooms, to better provide timely and relevant teaching tips to trainees and faculty who need to actively engage with their instructors, specifically for those in the patient care setting.

“The Just in Time Teaching Tools app allows for a more robust teaching and learning environment for everyone in the classroom,” said the app’s developer, Alice Fornari, EdD, RDN, the associate dean of educational skills development at Zucker School of Medicine at Hofstra/Northwell and vice president of faculty development at Northwell. “The use of technology-enhanced learning platforms are feasible and accessible to learners across the continuum of medical education and are especially useful in geographically dispersed academic health systems. This new app makes that model even stronger.”

In a pilot study – which utilized email to distribute JiTT infographics – trainees and faculty reported overall satisfaction with the content and technology and a positive perception by trainees’ of their enhanced teaching skills. Faculty expressed the JiTT infographics were useful reminders to refresh and guide their teaching skills with trainees and students.  Most importantly, it can be reported with certainty that the JiTT infographic program can be incorporated into busy diverse teaching and clinical settings.

JiTT infographics are adaptable to an array of clinical specialties and include foundational teaching principles in areas such as setting expectations, questioning techniques, feedback and coaching, and bedside teaching. Clinically specific teaching techniques include content pertaining to internal and family medicine, pediatrics, obstetrics and gynecology, surgery psychiatry and neurology. Sub-specialties are also included.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”